Translational Research Institute Plans Brisbane Facility

The Translational Research Institute (TRI) selected Watpac Construction in May of 2010 to construct its $354 million research facility in Brisbane. Located at Princess Alexandra Hospital, the TRI will house integrated facilities for the discovery, production, clinical testing, and manufacture of new biopharmaceuticals and therapies. Occupancy is expected in mid-2012. The TRI represents a partnership of Mater Medical Research Institute, the Queensland Government, the University of Queensland, Princess Alexandra Hospital, and Queensland University of Technology. The design team includes Wilson Architects and Donovan Hill. The facility will include a 6,500-sm mammalian biopharmaceutical manufacturing facility. The plant will be built by DSM and is expected to be operational by 2013.